Clinical Study

Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia

Figure 2

Effect of rimonabant on (a) weight at each visit and at 9 months (b) 5% and 10% weight responders.
957268.fig.002a
(a)
957268.fig.002b
(b)